Sodium-glucose transport-2 (SGLT-2) inhibitors clinical trials

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

This study looks at whether a drug called dapagliflozin can protect the heart of breast cancer patients receiving certain chemotherapy. This chemotherapy can sometimes cause heart damage, and researchers want to see if this new drug can reduce that risk.